Dr Peter Gawne received his Masters in Chemistry in 2015 from the University of Hull in the UK, before joining the Centre of Doctoral Training in Medical Imaging at King's and Imperial College London later that year. There he obtained a Masters of Research in Medical Imaging Sciences, and began his PhD project under the supervision of Dr Rafael T. M. de Rosales and Prof Nicholas Long. During his PhD, he investigated novel radioactive metal complexes for the radiolabelling, and in vivo imaging, of nanomedicines and cellular therapies using positron emission tomography (PET); and obtained his PhD in Radiochemistry in 2020. Following his PhD, Peter joined the KCL EPSRC MITHRAS programme as a Postdoctoral Researcher working on the radiolabelling of cells and nanomedicines. His research interests are focused on the use of in vivo imaging techniques (e.g. PET) to aid the validation and clinical translation of novel therapies.
Claudia Giambartolomei's interest lies in finding new ways of integrating large-scale genomic data to improve our understanding of the molecular mechanisms leading to differences in phenotypes and disease risk in human biology. She completed her Ph.D. in genomics of complex diseases at the University College of London, and has specialized on integrative methodologies in psychiatric disorders as a postdoctoral fellow at Mount Sinai Icahn School of Medicine and later on in Pasaniuc's lab at the University of California, Los Angeles.
Dr Flávia Sousa received her MSc in Pharmaceutical Sciences and her PhD in Biomedical Sciences at ICBAS, University of Porto. Before joining the MINDED programme, she carried out her post-doctoral training in the laboratories of Prof. Molly Stevens at Imperial College London and with Prof. Bruno Sarmento at I3S, University of Porto. Her research interests are related to the nanomedicine field, where she has built a solid foundation in nanobiomaterials-based delivery systems for a controlled release of biomacromolecules (monoclonal antibodies, proteins, peptides). Dr Flávia Sousa is an invited assistant professor at IUCS (Gandra, Portugal) and she belongs to the board of CRS Focus group in nanomedicine and nanoscale delivery as Trainee Representative.
Dr Corinne Portioli received her BSc in Biotechnology and MSc in Medical and Pharmaceutical Biotechnology from the University of Modena and Reggio Emilia, IT. She then obtained a PhD in Neuroscience at the University of Verona, IT and Doctor Europaeus due to her Visiting PhD student experience at the University of Manchester, UK. Corinne joined IIT (Cancedda and De Vivo Labs) in 2017 before moving to Baylor College of Medicine, US (Zhou Lab) to work on structural biology projects aimed at finding new cures for neurological diseases. From 2019 to 2021 she was Marie Skłodowska-Curie Individual Fellow (GF) Researcher with a project focused on elucidating the structure-function relationship of NKCC1, ion co-transporter, a promising drug target for neurodevelopmental disorders. She joined MINDED programme in July 2021 to work on the in vitro and in vivo characterization of drug delivery systems in neurodevelopmental disorders. Her research field focuses on the use of an interdisciplinary approach (cell/molecular biology, structural biology, computational chemistry and nanomedicine) to tackle the need of novel therapeutic treatments in neurological disorders.
Koray Ertan, Ph.D.
Martina Pannuzzo, Ph.D.
Elena Bellotti, Ph.D.
Shoshy Mizrahy, Ph.D.